10 Jahre DZD

Ergebnisse aus der Forschung möglichst schnell vom Labor zum Patienten zu bringen (Translation), um Diabetes besser vorbeugen und behandeln zu können sowie Folgeerkrankungen zu vermeiden, ist das Ziel des Deutschen Zentrums für Diabetesforschung (DZD). Das DZD wurde vor 10 Jahren, am 24. Juni 2009, auf Initiative des Bundesforschungsministeriums gegründet. Mehr als 400 Experten unterschiedlicher Disziplinen wie Grundlagenforschung, Epidemiologie, Versorgungsforschung und Klinik arbeiten gemeinsam an neuen personalisierten Präventions- und Therapiekonzepten. Mit Erfolg: Die Forschungsarbeiten des DZD helfen nicht nur, die Entstehung der Stoffwechselerkrankung besser zu verstehen, sondern legen auch wichtige Grundlagen für innovative Präventions- und Behandlungsverfahren.

• Literatur

• 1 Stefan N, Staiger H, Wagner R, Machann J. et al. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia 2015; 58 (12) 2877-2884 doi:10.1007/s00125-015-3760-z
• 2 Böhm A, Hoffmann C, Irmler M, Schneeweiss P. et al. TGF-beta Contributes to Impaired Exercise Response by Suppression of Mitochondrial Key Regulators in Skeletal Muscle. Diabetes 2016; 65 (10) 2849-2861 doi:10.2337/db15-1723
• 3 Szendroedi J, Saxena A, Weber KS, Strassburger K. et al. Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol 2016; 15: 59 doi:10.1186/s12933-016-0374-9
• 4 Weber KS, Nowotny B, Strassburger K, Pacini G. et al. The Role of Markers of Low-Grade Inflammation for the Early Time Course of Glycemic Control, Glucose Disappearance Rate, and beta-Cell Function in Recently Diagnosed Type 1 and Type 2 Diabetes. Diabetes Care 2015; 38 (09) 1758-1767 doi:10.2337/dc15-0169
• 5 Rathmann W, Strassburger K, Bongaerts B, Kuss O. et al. A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes. Diabetologia 2019; 62 (02) 286-291 doi:10.1007/s00125-018-4759-z
• 6 Kopf S, Groener JB, Kender Z, Fleming T. et al Breathlessness and Restrictive Lung Disease: An Important Diabetes-Related Feature in Patients with Type 2 Diabetes. Respiration 2018; 96 (01) 29-40 doi:10.1159/000488909
• 7 Clemmensen C, Finnan B, Müller TD, DiMarchi RD. et al. Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases. Nat Rev Endocrinol 2019; 15 (02) 90-104 doi:10.1038/s41574-018-0118-x
• 8 Solimena M, Schulte AM, Marselli L, Ehehalt F. et al. Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes. Diabetologia 2018; 61 (03) 641-657 doi:10.1007/s00125-017-4500-3
• 9 Bader E, Migliorini A, Gegg M, Morruzi N. et al. Identification of proliferative and mature beta-cells in the islets of Langerhans. Nature 2016; 535 (7612) 430-434 doi:10.1038/nature18624
• 10 Ludwig B, Ludwig S, Steffen A, Knauf Y. et al. Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes. Proc Natl Acad Sci U S A, 2017; 114 (44) 11745-11750 doi:10.1073/pnas.1708420114.
• 11 Ziegler AG, Bonifacio E, Powers AC, Todd JA. et al. Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease. Diabetes 2016; 65 (11) 3233-3239 doi:10.2337/db16-0687
• 12 von Toerne C, Huth C, de Las Heras Gala T, Kronenberg F. et al. MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study. Diabetologia 2016; 59 (09) 1882-1892 doi:10.1007/s00125-016-4024-2
• 13 Wittenbecher C, Ouni M, Kuxhaus O, Jähnert M. et al. Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes. Diabetes 2019; 68 (01) 188-197 doi:10.2337/db18-0620
• 14 Paprott R, Mühlenbruch K, Mensink GB, Thiele S. et al. Validation of the German Diabetes Risk Score among the general adult population: findings from the German Health Interview and Examination Surveys. BMJ Open Diabetes Res Care 2016; 4 (01) e000280 doi:10.1136/bmjdrc-2016-000280
• 15 Much D, Beyerlein A, Kindt A, Krumsiek J. et al. Lactation is associated with altered metabolomic signatures in women with gestational diabetes. Diabetologia 2016; 59 (10) 2193-2202 doi:10.1007/s00125-016-4055-8
• 16 Linder K, Schleger F, Kiefer-Schmidt I, Fritsche L. al. Gestational Diabetes Impairs Human Fetal Postprandial Brain Activity. J Clin Endocrinol Metab 2015; 100 (11) 4029-4036 doi:10.1210/jc.2015-2692
• 17 Rozman J, Rathkolb B, Oesterreicher MA, Schütt C. et al. Identification of genetic elements in metabolism by high-throughput mouse phenotyping. Nat Commun 2018; 9 (01) 288 doi:10.1038/s41467-017-01995-2
• 18 Vogel H, Kamitz A, Hallahan N, Lebek S. et al. A collective diabetes cross in combination with a computational framework to dissect the genetics of human obesity and Type 2 diabetes. Hum Mol Genet 2018; 27 (17) 3099-3112 doi:10.1093/hmg/ddy217
• 19 Huypens P, Sass S, Wu M, Dyckhoff D. et al. Epigenetic germline inheritance of diet-induced obesity and insulin resistance. Nat Genet 2016; 48 (05) 497-499 doi:10.1038/ng.3527
• 20 Blutke A, Renner S, Flenkenthaler F, Backmann M. et al. The Munich MIDY Pig Biobank – A unique resource for studying organ crosstalk in diabetes. Mol Metab 2017; 6 (08) 931-940 doi:10.1016/j.molmet.2017.06.004
• 21 Hernandez EA, Kahl S, Seelig A, Begovatz P. et al. Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J Clin Invest 2017; 127 (02) 695-708 doi:10.1172/JCI89444
• 22 Stefan N, Schick F, Häring HU. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371 (23) 2236-2237 doi:10.1056/NEJMc1412427
• 23 Koliaki C, Szendroedi J, Kaul K, Jelenik T. et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab 2015; 21 (05) 739-746 doi:10.1016/j.cmet.2015.04.004
• 24 Hess ME, Hess S, Meyer KD, Verhagen LA. et al. The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci 2013; 16 (08) 1042-1048 doi:10.1038/nn.3449
• 25 Heni M, Kullmann S, Preissl H, Fritsche A. et al. Impaired insulin action in the human brain: causes and metabolic consequences. Nat Rev Endocrinol 2015; 11 (12) 701-711 doi:10.1038/nrendo.2015.173
• 26 Gutmann T, Kim KH, Grzybek M, Walz T. et al. Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor. J Cell Biol 2018; 217 (05) 1643-1649 doi:10.1083/jcb.201711047